Our division has made significant contributions to research on irritable bowel syndrome, hepatitis C, fatty liver disease, functional gastrointestinal disorders, behavioral medicine, tele-hepatology and intestinal secretion.
In our division, you have opportunities to collaborate with accomplished physician-scientists on research projects investigating the pathogenesis, treatment and prevention of gastrointestinal diseases and hepatologic conditions.
Martinez et al. (2022) Hepatitis C virus prevalence and outcomes among pregnant women who inject drugs. 10th International Conference on Health and Hepatitis Care in Substance Users. Glasgow Scottland, (Dec)Poster